Epidermal Patch Simultaneously Monitors Hemodynamic and Metabolic Biomarkers
By LabMedica International staff writers Posted on 24 Mar 2021 |

Image: The first wearable device for simultaneous monitoring of hemodynamic and biochemical biomarkers (Photo courtesy of University of California, San Diego)
Intertwined with concepts of telehealth, the internet of medical things, and precision medicine, wearable sensors offer features to actively and remotely monitor physiological parameters. Monitoring of single physical parameters, such as the electrocardiogram and blood pressure (BP), as well as biochemical parameters, such as glucose, using non-invasive wearable sensors has been reported.
Heart rate (HR) and BP, two of the most important vital signs, can dynamically and directly reflect the physiological status of the body. These cardiovascular parameters can be affected by fluctuations of various biomarker concentrations originating from activities such as movement, stress or the intake of food, drinks and drugs that can lead to sudden and sometimes lethal alterations.
Nanoengineering experts at the University of California, San Diego (La Jolla, CA, USA) have developed an all-in-one health monitoring device that can reliably measure glucose, lactate, and blood pressure using a soft, stretchy skin patch the size of a postage stamp. It is notoriously difficult to do blood pressure monitoring and metabolite sensing at the same time in the human body due to signal interference when chemical and ultrasound hydrogels intermix.
The blood pressure sensor sits near the center of the device and consists of a set of small ultrasound transducers that are welded to the substrate by a conductive ink. A voltage applied to the transducers causes them to send ultrasound waves into the body and, when they bounce off an artery, the sensor detects the echoes and translates the signals into a blood pressure reading.
The chemical sensors are a pair of electrodes screen-printed on the patch from conductive ink. One electrode can sense either lactate (a biomarker of physical exertion), caffeine, or alcohol, and is printed on the right side of the patch together with the sweat stimulation system, which works by releasing the sweat-inducing drug pilocarpine into the skin for detection of chemical substances in that sweat. The other electrode senses glucose and is printed on the left side of the patch where the interstitial fluid extraction system is located. It works by passing a mild electrical current through the skin to pull out interstitial fluid so glucose can be measured in that fluid.
Glucose, lactate, alcohol, and blood pressure signals were validated against a commercial ACCU-CHEK glucometer (Roche Diagnostics, Indianapolis, IN, USA), blood-lactate meter (NOVA Biomedical, Waltham MA, USA), a BACtrack S80 Pro breathalyzer (San Francisco, CA, USA), and FDA-approved blood pressure cuff, respectively. Caffeine concentrations were estimated by standard addition methodology using collected sweat. An electrochemical impedance analyzer was used to stimulate sweat and extract interstitial fluid simultaneously.
The authors concluded that in human volunteers, the device captured physiological effects of food intake and exercise, in particular the production of glucose after food digestion, the consumption of glucose via glycolysis, and increases in blood pressure and heart rate compensating for oxygen depletion and lactate generation. The study was published on February 15, 2021 in the journal Nature Biomedical Engineering.
Related Links:
University of California, San Diego
Roche Diagnostics
NOVA Biomedical
BACtrack
Heart rate (HR) and BP, two of the most important vital signs, can dynamically and directly reflect the physiological status of the body. These cardiovascular parameters can be affected by fluctuations of various biomarker concentrations originating from activities such as movement, stress or the intake of food, drinks and drugs that can lead to sudden and sometimes lethal alterations.
Nanoengineering experts at the University of California, San Diego (La Jolla, CA, USA) have developed an all-in-one health monitoring device that can reliably measure glucose, lactate, and blood pressure using a soft, stretchy skin patch the size of a postage stamp. It is notoriously difficult to do blood pressure monitoring and metabolite sensing at the same time in the human body due to signal interference when chemical and ultrasound hydrogels intermix.
The blood pressure sensor sits near the center of the device and consists of a set of small ultrasound transducers that are welded to the substrate by a conductive ink. A voltage applied to the transducers causes them to send ultrasound waves into the body and, when they bounce off an artery, the sensor detects the echoes and translates the signals into a blood pressure reading.
The chemical sensors are a pair of electrodes screen-printed on the patch from conductive ink. One electrode can sense either lactate (a biomarker of physical exertion), caffeine, or alcohol, and is printed on the right side of the patch together with the sweat stimulation system, which works by releasing the sweat-inducing drug pilocarpine into the skin for detection of chemical substances in that sweat. The other electrode senses glucose and is printed on the left side of the patch where the interstitial fluid extraction system is located. It works by passing a mild electrical current through the skin to pull out interstitial fluid so glucose can be measured in that fluid.
Glucose, lactate, alcohol, and blood pressure signals were validated against a commercial ACCU-CHEK glucometer (Roche Diagnostics, Indianapolis, IN, USA), blood-lactate meter (NOVA Biomedical, Waltham MA, USA), a BACtrack S80 Pro breathalyzer (San Francisco, CA, USA), and FDA-approved blood pressure cuff, respectively. Caffeine concentrations were estimated by standard addition methodology using collected sweat. An electrochemical impedance analyzer was used to stimulate sweat and extract interstitial fluid simultaneously.
The authors concluded that in human volunteers, the device captured physiological effects of food intake and exercise, in particular the production of glucose after food digestion, the consumption of glucose via glycolysis, and increases in blood pressure and heart rate compensating for oxygen depletion and lactate generation. The study was published on February 15, 2021 in the journal Nature Biomedical Engineering.
Related Links:
University of California, San Diego
Roche Diagnostics
NOVA Biomedical
BACtrack
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Clinical Chemistry
view channelMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read moreMolecular Diagnostics
view channel
First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more
New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests
Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more
Biomarker Discovery Paves Way for Blood Tests to Detect and Treat Osteoarthritis
The number of individuals affected by osteoarthritis is projected to exceed 1 billion by 2050. The primary risk factor for this common, often painful chronic joint condition is aging, and, like aging itself,... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more